Igc PharmaIGC
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 35 institutions reported holding Igc Pharma Inc. (IGC) in their 13F filings, up 5 from Q4 2025. 7 opened new positions and 4 sold out. The largest holders were Geode Capital Management, LLC ($274K), Vanguard Capital Management LLC ($189K) and BlackRock, Inc. ($185K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Fisher (0.0% of Fisher Asset Management's portfolio).
- Company
- Igc Pharma Inc.
- CUSIP
- 45408X308
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $14K |
| Exits | 4 | $79K |
All 13F filers, Q4 2025 → Q1 2026: 284,092 shares bought and 787,839 shares sold, net −503,747 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Geode Capital Management, LLC | 0.00% | Add +21.3% | 1,043,384 | $274K |
| Vanguard Capital Management LLC | 0.00% | — | 718,436 | $189K |
| BlackRock, Inc. | 0.00% | No change | 703,798 | $185K |
| Renaissance Technologies | 0.00% | Reduce -47.4% | 483,975 | $127K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 415,888 | $109K |
| State Street Corp. | 0.00% | No change | 200,799 | $53K |
| Susquehanna International Group, LLP | 0.00% | Reduce -20.9% | 122,595 | $32K |
| Northern Trust Corp. | 0.00% | No change | 113,407 | $30K |
| Lawood & Co. | 0.02% | No change | 75,000 | $20K |
| Goldman Sachs Group Inc. | 0.00% | No change | 65,541 | $17K |
| Dearborn Partners LLC | 0.00% | Reduce -29.6% | 59,401 | $16K |
| XTX Topco Ltd | 0.00% | Add +78.8% | 50,648 | $13K |
| Fisher Asset Management | 0.00% | No change | 43,400 | $11K |
| Truist Financial Corp. | 0.00% | No change | 36,667 | $10K |
| Morgan Stanley | 0.00% | Add +98.3% | 35,118 | $9K |
| Commonwealth Equity Services, LLC | 0.00% | Add +1.5% | 33,848 | $9K |
| Virtu Financial LLC | 0.00% | New | 23,233 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +46.3% | 21,049 | $6K |
| T3 Companies, LLC | 0.01% | No change | 20,000 | $5K |
| Vanguard Global Advisers, LLC | 0.00% | — | 14,944 | $4K |
| Schneider Downs Wealth Management Advisors, LP | 0.00% | New | 10,000 | $3K |
| Wealthcare Advisory Partners LLC | 0.00% | New | 10,000 | $3K |
| HighTower Advisors, LLC | 0.00% | New | 10,000 | $3K |
| UBS Group AG | 0.00% | Reduce -59.3% | 8,097 | $2K |
| Trask Adam Roland | 0.00% | — | 5,000 | $1K |
| Group One Trading LLC | 0.00% | Reduce -47.7% | 3,762 | $989 |
| Geneos Wealth Management Inc. | 0.00% | No change | 3,000 | $780 |
| Cwm, LLC | 0.00% | New | 1,000 | $263 |
| Caitlin John, LLC | 0.00% | No change | 200 | $53 |
| Farther Finance Advisors, LLC | 0.00% | Add +1.0% | 101 | $27 |
| Hurley Capital, LLC | 0.00% | No change | 100 | $26 |
| DHJJ Financial Advisors, Ltd. | 0.00% | No change | 80 | $22 |
| Napier Financial, LLC | 0.00% | New | 58 | $15 |
| Johnson Financial Group, Inc. | 0.00% | New | 1 | $1 |
| Triumph Capital Management | 0.00% | No change | 2 | $1 |
"% of holder's portfolio" is IGC's weight in each manager's 13F, not the share of Igc Pharma Inc. the manager owns.